CVR 39982277Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Fruebjergvej 3, 2100 København ØFounded 30 Oct 2018
Qlife ApS
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Qlife ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
3
CVR, 2024
Gross profit
-6.5M
DKK, annual report 2023
Result
-104.8M
DKK, annual report 2023
Equity
-85.9M
DKK, annual report 2023
Qlife Holding AB100% of capital and votes
Operating company
Dandex estimate: no recent employees or annual report figures to go on; status is not activeThomas Warthoeuntil 24 Jul 2024
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votesnotified 31 Oct 2019since 10 Oct 2019
CVR 100501545% to under 10% of votesnotified 16 Aug 201921 Jan 2019 to 2 Aug 2019
CVR 340420125% to under 10% of capital and votesnotified 31 Oct 201921 Jan 2019 to 10 Oct 2019
CVR 369853565% to under 10% of votesnotified 16 Aug 201921 Jan 2019 to 2 Aug 2019
CVR 3997412650% to under 66.7% of capital and votesnotified 31 Oct 201930 Oct 2018 to 10 Oct 2019
5% to under 10% of votesnotified 22 Jan 201921 Jan 2019 to 2 Aug 2019
5% to under 10% of votesnotified 22 Jan 201921 Jan 2019 to 2 Aug 2019
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jun 2024, monthly: 3 employees, 3 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 4 | 5 | 6 | 7 | 7 | 11 | 12 | 13 | 14 | 15 | 14 | 15 | 17 | 18 | 29 | 32 | 32 | 26 | 32 | 35 | 34 | 41 | 41 | 41 | 39 | 41 | 40 | 39 | 40 | 46 | 46 | 48 | 52 | 56 | 64 | 64 | 68 | 70 | 68 | 68 | 67 | 66 | 64 | 58 | 57 | 50 | 49 | 40 | 38 | 38 | 32 | 28 | 22 | 19 | 17 | 15 | 15 | 15 | 12 | 12 | 12 | 12 | 3 | 3 |
| FTE | 4 | 4 | 6 | 6 | 5 | 9 | 10 | 11 | 13 | 13 | 13 | 14 | 16 | 16 | 19 | 21 | 20 | 20 | 29 | 32 | 31 | 34 | 36 | 36 | 36 | 36 | 36 | 36 | 35 | 39 | 40 | 44 | 45 | 47 | 55 | 58 | 62 | 64 | 64 | 60 | 59 | 60 | 57 | 54 | 51 | 46 | 38 | 36 | 34 | 33 | 28 | 25 | 20 | 17 | 15 | 14 | 14 | 15 | 12 | 12 | 12 | 12 | 3 | 3 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Jun 2024, published 23 Aug 2024.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2023, DKK: Gross profit -6.5M, Operating profit -100.8M, Result for the year -104.8M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2023, DKK: Total assets 25.7M, Equity -85.9M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Gross profit | Not reported | 3,732 | 7,345 | -8,182 | -6,497 |
| Operating profit | -8,015 | -12,491 | -27,548 | -64,036 | -100,833 |
| Result for the year | -8,618 | -5,949 | -22,320 | -56,084 | -104,752 |
| Equity | 7,733 | 31,784 | 39,464 | -16,621 | -85,949 |
| Total assets | 17,508 | 57,104 | 78,998 | 123,491 | 25,723 |
| Employees (average) | 10 | 15 | 39 | 58 | 24 |
Not every period is a full year: 2019 covers 14 months (30 Oct 2018 to 31 Dec 2019). Changes against it compare periods of different length.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 12,767,104, cash price 560.60, implied value 48,167,313 | 560.60 | 12,767,104 | 48,167,313 | 85,921 | |
| IncreaseCashPaid in 1,464,180, cash price 460.00, implied value 29,047,620 | 460.00 | 1,464,180 | 29,047,620 | 63,147 | |
| IncreaseDebt conversion, cashPaid in 39,230, cash price 4.60, implied value 275,834 | 4.60 | 39,230 | 275,834 | 59,964 | |
| FoundingCashPaid in 56,920, cash price 1.14 | 1.14 | 56,920 | None | 50,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Gross profit growth (vækst i bruttofortjeneste) | Not reportednote 1 | 302.3% | 96.8% | -211.4% | n.m.note 2 |
| EBITDA | -7,854 | -11,748 | -21,226 | -51,391 | -26,821 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | 50% | 160% | 48.7% | -58.6% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 3 | 20,081note 4 | 20,159note 4 | 71,396note 4 | 18,374note 4 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
21 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Konkursdekret afsagt 24.07.2024 af Sø- og Handelsrettens Skifteretsafdeling
Bestyrelse:
Fratrådte:
Lars Bangsgaard, (formand), den 24.07.2024, Thomas Warthoe, den 24.07.2024, Lars Aage Staal Wegner, den 24.07.2024.
Direktion:
Fratrådte:
Thomas Warthoe, (adm. dir), den 24.07.2024.
Revision:
Fratrådte:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, den 24.07.2024.
Sø- og Handelsrettens Skifteretsafdeling har 27.03.2024 indledt rekonstruktionsbehandling
Ny adresse: Fruebjergvej 3, 2100 København Ø
Ny kommune: København
Vedtægter ændret: 30.10.2023
Slettet binavn: Egoo.Health ApS
Bestyrelse:
Fratrådte:
Mette Gross, (formand), den 22.05.2023, John Erik Moll Andersson, den 22.05.2023.
Tiltrådte:
Lars Bangsgaard, (formand), den 22.05.2023, Lars Aage Staal Wegner, den 22.05.2023.
Ny adresse: Industriparken 39, 2750 Ballerup
Bestyrelse:
Fratrådte:
Niklas Marschall, den 21.09.2021.
Vedtægter ændret: 18.06.2020
Nyt binavn: Egoo.Health ApS
Formål ændret: Selskabets formål er at udvikle, designe, producere og sælge biomarkør hjemme- og selvtests med samme kvalitet som high performance laboratorieudstyr.
Revision:
Fratrådte:
Kreston CM Statsautoriseret Revisions interessentskab, den 20.05.2020.
Tiltrådte:
CVR-NR. 20222670 BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, Havneholmen 29, 1561 København V, den 20.05.2020.
Bestyrelse:
Tiltrådte:
Thomas Warthoe, den 13.01.2020.
Revision:
Tiltrådte:
CVR-NR. 39463113 Kreston CM Statsautoriseret Revisions interessentskab, Adelgade 15, 1304 København K, den 13.01.2020.
Vedtægter ændret: 12.11.2019
Ny adresse: Borupvang 3, 2750 Ballerup
Ny kommune: Ballerup
Bestyrelse:
Fratrådte:
Pernille Kristine Veje Gordon, (formand), den 12.11.2019, Anders Kjær, den 12.11.2019.
Tiltrådte:
Mette Gross, (formand), den 12.11.2019.
Vedtægter ændret: 02.08.2019
Kapitalforhøjelsen er besluttet den 02.08.2019.
kr. 22.774,00, indbetalt kontant, kurs 56.060,00.
Kapitalen udgør herefter kr. 85.921,00.
Vedtægter ændret: 01.04.2019
Kapitalforhøjelsen er besluttet den 01.04.2019.
kr. 3.183,00, indbetalt kontant, kurs 46.000,00.
Kapitalen udgør herefter kr. 63.147,00.
Vedtægterne er yderligere ændret
Vedtægter ændret: 21.01.2019
Selskabet tegnes af tre bestyrelsesmedlemmer eller af selskabets administrerende direktør og bestyrelsesformanden i forening..
Vedtægter ændret: 21.01.2019
Kapitalforhøjelsen er besluttet den 21.01.2019.
kr. 2.540,00, indbetalt ved konvertering af gæld, kurs 200,00. kr. 7.424,00, indbetalt kontant, kurs 460,00.
Kapitalen udgør herefter kr. 59.964,00.
Direktion:
Fratrådte:
Thomas Wartho, (adm. dir), den 15.11.2018.
Tiltrådte:
Thomas Warthoe, (adm. dir), den 15.11.2018.
Bestyrelse:
Tiltrådte:
Pernille Kristine Veje, (formand), den 15.11.2018.
Direktion:
Fratrådte:
Pernille Kristine Veje, den 15.11.2018.
Tiltrådte:
Thomas Wartho, (adm. dir), den 15.11.2018.
Stiftelsesdato: 30.10.2018.
Virkningsdato: 30.10.2018.
Seneste vedtægtsdato: 30.10.2018.
Kapital:
kr. 50.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 50.000,00 til kurs 113,84, fuldt indbetalt.
Stifter:
CVR-NR. 39974126 PKV Consult IVS, Hvilegårdsparken 52, 3320 Skævinge, den 30.10.2018.
Direktion:
Pernille Kristine Veje, den 30.10.2018.
Selskabet tegnes af 1 direktør..
Første regnskabsår:
30.10.2018 - 31.12.2019.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at yde forskning og eksperimentel udvikling inden for bioteknologi samt anden i denne forbindelse hermed stående eller afledt virksomhed.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for Qlife ApS:
Have Pro? Sign in.
P-number 1026030370Messingvej 44, 8940 Randers SV
P-number 1024083841Fruebjergvej 3, 2100 København Ø
P-number 1025880982Fruebjergvej 3, 2100 København Ø